COVID-19 surge: Ashok Gehlot asks Centre for 30 lakh vaccine doses, says Rajasthan's stock to end in 2 days

Gehlot's demand before Prime Minister Narendra Modi comes on the heels of similar requests being made from states like Maharashtra and Gujarat

Press Trust of India April 09, 2021 21:30:44 IST
COVID-19 surge: Ashok Gehlot asks Centre for 30 lakh vaccine doses, says Rajasthan's stock to end in 2 days

File image of Rajasthan chief minister Ashok Gehlot.

Jaipur: Rajasthan chief minister Ashok Gehlot has written to Prime Minister Narendra Modi, saying the stock of coronavirus vaccine in the state will finish in next two days and urged him to immediately provide at least 30 lakh doses.

In a letter to the prime minister after a video conference with him on Thursday, Gehlot said the state aimed at vaccinating five lakh people every day and has administered 86,89,770 doses from 16 January to 7 April.

We have already planned to increase the pace of vaccination to five lakh beneficiaries per day through a collaborative approach and effective mobilisation of beneficiaries, " Gehlot said.

"The present stock of vaccine in Rajasthan will finish in next two days. Therefore, it is requested that at least another 30 lakh doses of vaccine be provided to us immediately so that the momentum that we have built up can be maintained and maximum eligible beneficiaries can be vaccinated at the earliest," he said.

"I want to assure you that we will leave no stone unturned in our efforts to control COVID-19 ," he added.

Updated Date:

also read

Joe Biden sets new COVID-19 vaccination goal, aims to inoculate 70% of US adults by 4 July
World

Joe Biden sets new COVID-19 vaccination goal, aims to inoculate 70% of US adults by 4 July

Already more than 56 percent of American adults have received at least one dose of a COVID-19 vaccine and nearly 105 million are fully vaccinated

COVID-19 vaccine supply crisis: Centre should amend Income Tax Act, invoke Companies Act, 2013 for manufacturers
India

COVID-19 vaccine supply crisis: Centre should amend Income Tax Act, invoke Companies Act, 2013 for manufacturers

Government needs to do is to call the bluff on "profits" and so called "super profits" which are allegedly required to re-investment and R&D to produce more vaccines. An urgent amendment to the Income Tax Act, 1961 is needed.

COVID-19 vaccine: Bharat Biotech commences direct supply of Covaxin to 14 states
India

COVID-19 vaccine: Bharat Biotech commences direct supply of Covaxin to 14 states

The Hyderabad-based firm has started supplying its COVID-19 vaccine to the states based on the allocations received by the central government